These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 37916145)

  • 1. Exploring the mechanism of traditional Chinese medicine in regulating gut-derived 5-HT for osteoporosis treatment.
    Sun K; Wang Y; Du J; Wang Y; Liu B; Li X; Zhang X; Xu X
    Front Endocrinol (Lausanne); 2023; 14():1234683. PubMed ID: 37916145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional Chinese Medicine in Osteoporosis Intervention and the Related Regulatory Mechanism of Gut Microbiome.
    Li K; Jiang Y; Wang N; Lai L; Xu S; Xia T; Yue X; Xin H
    Am J Chin Med; 2023; 51(8):1957-1981. PubMed ID: 37884447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fat's loss is bone's gain.
    Pei L; Tontonoz P
    J Clin Invest; 2004 Mar; 113(6):805-6. PubMed ID: 15067310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5).
    Warden SJ; Robling AG; Haney EM; Turner CH; Bliziotes MM
    Bone; 2010 Jan; 46(1):4-12. PubMed ID: 19591966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain neural effects of the 'tonifying kidney and benefiting marrow' method in the treatment of osteoporosis.
    Xu Y; Liu X; Li H; Liu H; Pan Z; Chen G
    J Tradit Chin Med; 2019 Dec; 39(6):902-909. PubMed ID: 32186162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and Treatment of Osteoporosis Using Chinese Medicinal Plants: Special Emphasis on Mechanisms of Immune Modulation.
    Zhao H; Zhao N; Zheng P; Xu X; Liu M; Luo D; Xu H; Ju D
    J Immunol Res; 2018; 2018():6345857. PubMed ID: 29675436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical studies and clinical evaluation of compounds from the genus Epimedium for osteoporosis and bone health.
    Indran IR; Liang RL; Min TE; Yong EL
    Pharmacol Ther; 2016 Jun; 162():188-205. PubMed ID: 26820757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese Herbal Medicine Guilu Erxian Glue Inhibits Osteoclast Formation and Activity via Mc3t3-Derived Extracellular Vesicles in vitro.
    Si Y; Li S; Guo Y; Wang L; Ma Y; Yin H
    Altern Ther Health Med; 2023 Sep; 29(6):400-407. PubMed ID: 37384403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mechanism of Bone Remodeling After Bone Aging.
    Fang H; Deng Z; Liu J; Chen S; Deng Z; Li W
    Clin Interv Aging; 2022; 17():405-415. PubMed ID: 35411139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunolocalization of the prostaglandin E2 receptor subtypes in human bone tissue: differences in foetal, adult normal, osteoporotic and pagetic bone.
    Fortier I; Gallant MA; Hackett JA; Patry C; de Brum-Fernandes AJ
    Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):431-9. PubMed ID: 15062845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role for therapies targeting DKK1, LRP5, and serotonin in the treatment of osteoporosis.
    Zhang W; Drake MT
    Curr Osteoporos Rep; 2012 Mar; 10(1):93-100. PubMed ID: 22210558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary osteoporosis or secondary contributors to bone loss in fracture. The relevance of immune system to bone metabolism].
    Tanaka Y
    Clin Calcium; 2013 Sep; 23(9):1265-70. PubMed ID: 23999361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of 5-hydroxytryptamine 6 receptor accelerates maturation of bone-resorbing osteoclasts and induces bone loss.
    Park KR; Kim EC; Hong JT; Yun HM
    Theranostics; 2018; 8(11):3087-3098. PubMed ID: 29896304
    [No Abstract]   [Full Text] [Related]  

  • 14. The potential benefits and mechanisms of protein nutritional intervention on bone health improvement.
    Yu Y; Li X; Zheng M; Zhou L; Zhang J; Wang J; Sun B
    Crit Rev Food Sci Nutr; 2024 Jun; 64(18):6380-6394. PubMed ID: 36655469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD39 Produced from Human GMSCs Regulates the Balance of Osteoclasts and Osteoblasts through the Wnt/β-Catenin Pathway in Osteoporosis.
    Wu W; Xiao Z; Chen Y; Deng Y; Zeng D; Liu Y; Huang F; Wang J; Liu Y; Bellanti JA; Rong L; Zheng SG
    Mol Ther; 2020 Jun; 28(6):1518-1532. PubMed ID: 32304668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piezoelectric Microvibration Mitigates Estrogen Loss-Induced Osteoporosis and Promotes Piezo1, MicroRNA-29a, and Wnt3a Signaling in Osteoblasts.
    Wu RW; Lian WS; Chen YS; Ko JY; Wang SY; Jahr H; Wang FS
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cistanche Deserticola for Regulation of Bone Metabolism: Therapeutic Potential and Molecular Mechanisms on Postmenopausal Osteoporosis.
    Wang C; Li F; Li Y; Feng H; Zhao MW; Tu PF; Tian H
    Chin J Integr Med; 2023 Jan; 29(1):74-80. PubMed ID: 35930138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of weightlessness osteoporosis and preventive and therapeutic effect of traditional Chinese medicine].
    Zhu B; Guo H; Hao XJ; Fu Q; Hu SM
    Zhongguo Gu Shang; 2012 Jul; 25(7):611-6. PubMed ID: 23116001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems of osteoporosis: study of biochemical markers of bone metabolism].
    Nasonov EL
    Klin Med (Mosk); 1998; 76(5):20-5. PubMed ID: 9644930
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathophysiology of bone metabolism].
    Jakob F; Seefried L; Ebert R
    Internist (Berl); 2008 Oct; 49(10):1159-60, 1162, 1164 passim. PubMed ID: 18810375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.